Remove company
article thumbnail

23andMe CEO plans to take company private

Bio Pharma Dive

Company head Anne Wojcicki is considering buying all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

DNA 245
article thumbnail

Gene therapy biotech Jaguar spins out manufacturing company

Bio Pharma Dive

Called Advanced Medicine Partners, the new company will offer specialized cell and gene therapy manufacturing services to biotech and pharma clients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ultragenyx to spin out new company around Alzheimer’s gene therapy

Bio Pharma Dive

CEO Emil Kakkis says the company's findings are too exciting to ignore, but the “high-risk, high-return” venture needs to be pursued outside the organization.

article thumbnail

Pharmaceutical packaging companies and labelling machines

Pharmaceutical Technology

Download our extensive, free list of the leading pharmaceutical packaging companies and labelling machine manufacturers today.

Packaging 130
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials.

article thumbnail

Innovation in immuno-oncology: Leading companies in microbiota restoration therapy

Pharmaceutical Technology

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

article thumbnail

BioNTech acquires tech company InstaDeep for $549m

Pharmaceutical Technology

BioNTech has acquired all the remaining shares of technology company InstaDeep in a deal valued at €500m ($549m) in cash.

246
246
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinical trials.

article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Former VP, Sales for $15 Billion Medical Supply Company. Simple strategies to become more memorable to your customer, thus maximizing your sales success. Who is Steve Goldstein and what are his credentials? Coached over 2000 sales reps worldwide. Toastmasters Champion. Dale Carnegie Sales Coach/Human Relations Award Winner.